Selected research
Industry Research
Integrated Precision Diagnosis and Treatment Solution Industry Research Report 2026
Market perspective
The global Integrated Precision Diagnosis and Treatment Solution market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Integrated Precision Diagnosis and Treatment Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Integrated Precision Diagnosis and Treatment Solution market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Integrated Precision Diagnosis and Treatment Solution market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Integrated Precision Diagnosis and Treatment Solution include Illumina, QIAGEN, Caris Life Sciences, Foundation Medicine, Guardant Health, NeoGenomics, Myriad Genetics, Thermo Fisher Scientific and Roche Holding AG, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Integrated Precision Diagnosis and Treatment Solution market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Integrated Precision Diagnosis and Treatment Solution.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Integrated Precision Diagnosis and Treatment Solution Market by Company
Illumina
QIAGEN
Caris Life Sciences
Foundation Medicine
Guardant Health
NeoGenomics
Myriad Genetics
Thermo Fisher Scientific
Roche Holding AG
Abbott Laboratories
GE HealthCare
Tempus Labs
Personalis
Genome Medical
Endeavor Biomedicines
Integrated Precision Diagnosis and Treatment Solution Segment by Type
Genomics
Proteomics
Metabolomics
Radiomics
Integrated Precision Diagnosis and Treatment Solution Segment by Application
Medical Institutions
Research and Academic Institutions
Integrated Precision Diagnosis and Treatment Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Integrated Precision Diagnosis and Treatment Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Integrated Precision Diagnosis and Treatment Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Integrated Precision Diagnosis and Treatment Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Integrated Precision Diagnosis and Treatment Solution companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Genomics
- Proteomics
- Metabolomics
- Radiomics
Applications
- Medical Institutions
- Research and Academic Institutions
Companies covered
- Illumina
- QIAGEN
- Caris Life Sciences
- Foundation Medicine
- Guardant Health
- NeoGenomics
- Myriad Genetics
- Thermo Fisher Scientific
- Roche Holding AG
- Abbott Laboratories
- GE HealthCare
- Tempus Labs
- Personalis
- Genome Medical
- Endeavor Biomedicines
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Integrated Precision Diagnosis and Treatment Solution by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Genomics
- 2.2.3 Proteomics
- 2.2.4 Metabolomics
- 2.2.5 Radiomics
- 2.3 Integrated Precision Diagnosis and Treatment Solution by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Medical Institutions
- 2.3.3 Research and Academic Institutions
- 2.4 Assumptions and Limitations
3 Integrated Precision Diagnosis and Treatment Solution Breakdown Data by Type
- 3.1 Global Integrated Precision Diagnosis and Treatment Solution Historic Market Size by Type (2021-2026)
- 3.2 Global Integrated Precision Diagnosis and Treatment Solution Forecasted Market Size by Type (2027-2032)
4 Integrated Precision Diagnosis and Treatment Solution Breakdown Data by Application
- 4.1 Global Integrated Precision Diagnosis and Treatment Solution Historic Market Size by Application (2021-2026)
- 4.2 Global Integrated Precision Diagnosis and Treatment Solution Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Integrated Precision Diagnosis and Treatment Solution Market Perspective (2021-2032)
- 5.2 Global Integrated Precision Diagnosis and Treatment Solution Growth Trends by Region
- 5.2.1 Global Integrated Precision Diagnosis and Treatment Solution Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Integrated Precision Diagnosis and Treatment Solution Historic Market Size by Region (2021-2026)
- 5.2.3 Integrated Precision Diagnosis and Treatment Solution Forecasted Market Size by Region (2027-2032)
- 5.3 Integrated Precision Diagnosis and Treatment Solution Market Dynamics
- 5.3.1 Integrated Precision Diagnosis and Treatment Solution Industry Trends
- 5.3.2 Integrated Precision Diagnosis and Treatment Solution Market Drivers
- 5.3.3 Integrated Precision Diagnosis and Treatment Solution Market Challenges
- 5.3.4 Integrated Precision Diagnosis and Treatment Solution Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Integrated Precision Diagnosis and Treatment Solution Players by Revenue
- 6.1.1 Global Top Integrated Precision Diagnosis and Treatment Solution Players by Revenue (2021-2026)
- 6.1.2 Global Integrated Precision Diagnosis and Treatment Solution Revenue Market Share by Players (2021-2026)
- 6.2 Global Integrated Precision Diagnosis and Treatment Solution Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Integrated Precision Diagnosis and Treatment Solution Head Office and Area Served
- 6.4 Global Integrated Precision Diagnosis and Treatment Solution Players, Product Type & Application
- 6.5 Global Integrated Precision Diagnosis and Treatment Solution Manufacturers Established Date
- 6.6 Global Integrated Precision Diagnosis and Treatment Solution Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Integrated Precision Diagnosis and Treatment Solution Market Size (2021-2032)
- 7.2 North America Integrated Precision Diagnosis and Treatment Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2021-2026)
- 7.4 North America Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Integrated Precision Diagnosis and Treatment Solution Market Size (2021-2032)
- 8.2 Europe Integrated Precision Diagnosis and Treatment Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2021-2026)
- 8.4 Europe Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size (2021-2032)
- 9.2 Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Integrated Precision Diagnosis and Treatment Solution Market Size (2021-2032)
- 10.2 South America Integrated Precision Diagnosis and Treatment Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2021-2026)
- 10.4 South America Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Size (2021-2032)
- 11.2 Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Illumina
- 12.1.1 Illumina Company Information
- 12.1.2 Illumina Business Overview
- 12.1.3 Illumina Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2021-2026)
- 12.1.4 Illumina Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 12.1.5 Illumina Recent Developments
- 12.2 QIAGEN
- 12.2.1 QIAGEN Company Information
- 12.2.2 QIAGEN Business Overview
- 12.2.3 QIAGEN Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2021-2026)
- 12.2.4 QIAGEN Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 12.2.5 QIAGEN Recent Developments
- 12.3 Caris Life Sciences
- 12.3.1 Caris Life Sciences Company Information
- 12.3.2 Caris Life Sciences Business Overview
- 12.3.3 Caris Life Sciences Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2021-2026)
- 12.3.4 Caris Life Sciences Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 12.3.5 Caris Life Sciences Recent Developments
- 12.4 Foundation Medicine
- 12.4.1 Foundation Medicine Company Information
- 12.4.2 Foundation Medicine Business Overview
- 12.4.3 Foundation Medicine Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2021-2026)
- 12.4.4 Foundation Medicine Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 12.4.5 Foundation Medicine Recent Developments
- 12.5 Guardant Health
- 12.5.1 Guardant Health Company Information
- 12.5.2 Guardant Health Business Overview
- 12.5.3 Guardant Health Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2021-2026)
- 12.5.4 Guardant Health Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 12.5.5 Guardant Health Recent Developments
- 12.6 NeoGenomics
- 12.6.1 NeoGenomics Company Information
- 12.6.2 NeoGenomics Business Overview
- 12.6.3 NeoGenomics Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2021-2026)
- 12.6.4 NeoGenomics Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 12.6.5 NeoGenomics Recent Developments
- 12.7 Myriad Genetics
- 12.7.1 Myriad Genetics Company Information
- 12.7.2 Myriad Genetics Business Overview
- 12.7.3 Myriad Genetics Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2021-2026)
- 12.7.4 Myriad Genetics Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 12.7.5 Myriad Genetics Recent Developments
- 12.8 Thermo Fisher Scientific
- 12.8.1 Thermo Fisher Scientific Company Information
- 12.8.2 Thermo Fisher Scientific Business Overview
- 12.8.3 Thermo Fisher Scientific Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2021-2026)
- 12.8.4 Thermo Fisher Scientific Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 12.8.5 Thermo Fisher Scientific Recent Developments
- 12.9 Roche Holding AG
- 12.9.1 Roche Holding AG Company Information
- 12.9.2 Roche Holding AG Business Overview
- 12.9.3 Roche Holding AG Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2021-2026)
- 12.9.4 Roche Holding AG Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 12.9.5 Roche Holding AG Recent Developments
- 12.10 Abbott Laboratories
- 12.10.1 Abbott Laboratories Company Information
- 12.10.2 Abbott Laboratories Business Overview
- 12.10.3 Abbott Laboratories Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2021-2026)
- 12.10.4 Abbott Laboratories Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 12.10.5 Abbott Laboratories Recent Developments
- 12.11 GE HealthCare
- 12.11.1 GE HealthCare Company Information
- 12.11.2 GE HealthCare Business Overview
- 12.11.3 GE HealthCare Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2021-2026)
- 12.11.4 GE HealthCare Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 12.11.5 GE HealthCare Recent Developments
- 12.12 Tempus Labs
- 12.12.1 Tempus Labs Company Information
- 12.12.2 Tempus Labs Business Overview
- 12.12.3 Tempus Labs Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2021-2026)
- 12.12.4 Tempus Labs Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 12.12.5 Tempus Labs Recent Developments
- 12.13 Personalis
- 12.13.1 Personalis Company Information
- 12.13.2 Personalis Business Overview
- 12.13.3 Personalis Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2021-2026)
- 12.13.4 Personalis Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 12.13.5 Personalis Recent Developments
- 12.14 Genome Medical
- 12.14.1 Genome Medical Company Information
- 12.14.2 Genome Medical Business Overview
- 12.14.3 Genome Medical Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2021-2026)
- 12.14.4 Genome Medical Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 12.14.5 Genome Medical Recent Developments
- 12.15 Endeavor Biomedicines
- 12.15.1 Endeavor Biomedicines Company Information
- 12.15.2 Endeavor Biomedicines Business Overview
- 12.15.3 Endeavor Biomedicines Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2021-2026)
- 12.15.4 Endeavor Biomedicines Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 12.15.5 Endeavor Biomedicines Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst